Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-71,page-paged-71,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • ABIVAX secures up to EUR 20m Debt Financing from Kreos Capital
    www.abivax.com
  • Apogenix Provides Update on Clinical Development of Asunercept
    www.apogenix.com
  • Secarna Pharmaceuticals introduces LNAplusTM, its proprietary, customized, third generation antisense oligonucleotide (ASO) drug discovery and development platform
    www.secarna.com
  • TxCell provides details of CAR-Treg manufacturing process at CAR-TCR Summit Europe
    www.medigene.com
  • Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD
    www.veronapharma.com
  • NOXXON to present latest clinical data from NOX-A12 / KEYTRUDA® combination trial at the 2019 AACR Annual Meeting
    www.noxxon.com
  • Newron Supports Global Rare Disease Day® 2019
    www.newron.com
  • Ergomed and PSR Orphan Experts, Ergomed’s rare disease specialist division, announce 2019 activities in support of Rare Disease Day®
    www.ergomedplc.com
  • Medigene AG: Medigene presents poster on in vitro evaluation of TCR efficacy and toxicity at AACR
    www.medigene.com
  • MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis
    www.morphosys.com